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ABSTRACT
Introducción: The exoU gene, a marker for highly virulent strains of 
Pseudomonas aeruginosa, is the major contributor to a wide variety 
of healthcare-associated infections. Methods: In this study, the anti-
biotic susceptibility profile, prevalence and genotyping of exoU+ P. 
aeruginosa were demonstrated. A total of 101 isolates of P. aerugino-
sa were analysed from different clinical and environmental sources. 
Results: The antibiotic susceptibility profile classified these isolates 
as extensively drug resistant (35.6%), multidrug resistant (40.5%) and 
non-multidrug resistant (23.7%). The prevalence of exoU gene was 
screened by PCR and 23 exoU+ genotypes were detected which all 
were clinical isolates. Multilocus sequence typing (MLST) analysis 
of seven loci assigned these exoU+ genotypes to 21 sequence types 
(STs) from which 16 new STs were identified. The prevalent STs were 
ST-308 and ST-235. Phylogenetic analysis using the concatenated nu-
cleotide sequences of the seven housekeeping genes, exoU and the 
ITS region differentiated these exoU+ strains into five main groups. 
However, distinct evolutionary origins for some new sequence types 
were also indicated. Conclusions: The studied isolates showed the co-
existence of exoU- and exoU+ genotypes of clinical P. aeruginosa in 
Kurdistan with a majority of MDR and XDR pattern. The prevalent 
STs found in other hospitals worldwide and at the international level.
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INTRODUCTION
The Gram-negative bacterium Pseudomonas aerugino-
sa is ubiquitous and widespread microorganism in a 
variety of  environments such as soil, water and on 
hosts(1).  In spite of  its wide spread in nature and the 
potential to cause community-acquired infections, 
this opportunistic pathogen is predominantly associ-
ated with hospital-acquired infections, including re-
spiratory infections, bacteremia, skin and soft tissue 
infections, osteomyelitis, urinary tract infections, gas-
troenteritis, otitis and eye infections(2, 3, 4). The severi-
ty of  P. aeruginosa infections is further complicated in 
immunocompromised patients or patients who are 
requiring mechanical ventilation(5). It has also been 
proven that P. aeruginosa has an extraordinary capaci-
ty to easily develop powerful resistance to almost all 
commercially available antibiotics either by the ac-
quisition of  horizontally transferred resistance genes 
or by mutation in chromosomally encoded genes(6, 7). 
These make infections caused by this pathogenoften 
difficult to treat and frequently life threatening due 
to its multidrug-resistant (MDR) phenotypes(8, 6).
The pathogenesis of  this bacterium is multifactorial; 
multiple and diverse determinants of  virulence con-
tribute to the wide range of  diseases caused(9). P. aeru-
ginosa possesses type III secretion system (T3SS) as a 
complex macromolecular machinery to inject and in-
toxicate host cells with up to four effector proteins; 
ExoS, ExoT, ExoY and ExoU(10). The exoUgene en-
codes the highly cytotoxic T3SS effector ExoU(11). 
This toxin has a phospholipase A2 activity that is 
highly cytotoxic to a range of  eukaryotic cells; ExoU 
disrupts cell membranes following its delivery into 
the cytoplasm and causes rapid celldeath(12). It has 
been reported that exoU gene is present in cytotox-
ic strains of P. aeruginosa, while non-cytotoxic strains 
lack this particular gene(13), making the presence of  
exoUa marker to identify highly virulent strains of  
this bacterium(14). The production of  ExoUis asso-
ciated with increased mortality and disease severity, 
and has been recognized as a major detrimental vir-
ulence factor in acute illnesses(13).  
The precise characterization of  species in clinical 
settings may have consequences in diagnosis, antimi-
crobial therapy, and infection control policies(15). To 
assess the genetic micro- and macro-variations used 
in epidemiological investigations, the genetic related-
ness among pathogenic isolates must be established 
by phylogenetic- and population-based analysis(16). 
Multilocus sequence typing (MLST), as a genotyping 
method based on the nucleotide sequence analysis 
and the allelic differences among seven house-keep-
ing genes (acsA, aroE, guaA, mutL, nuoD, ppsA, and 
trpE), has been widely used for genetic diversity and 
epidemiological investigation of  P. aeruginosa(17, 18). 
Although it relies only on the evaluation of  the core 
genome diversity, it is a robust, standard and por-
table technique that has been proven to be a valu-
able tool for analyzing the epidemiology of  bacterial 
infection, as it is highly discriminating and provides 
insight into genetic structure of  infected populations 
(19, 20, 21). It also provides a comprehensive database 
that allows researchers to compare the results ob-
tained from different sample types in different loca-
tions(22).
It has been previously reported that P. aeruginosa ac-
counted for 26.1% of  the total nosocomial infec-
tions in Kurdistan(23). A higher prevalence has been 
reported by studies elsewhere in Iraq, such as 46.6% 
in Najaf(24) and 67.7% in Basrah(25). However, to our 
knowledge, there is no comprehensive investigation 
or previous report from Kurdistan investigating the 
prevalence and genotype properties ofexoU+ P. aeru-
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ginosa isolates in this region. Therefore, in this pres-
ent study we performed a molecular identification 
and genotyping analysis of  P. aeruginosa isolates ob-
tained from soil and a range of  clinical infections at 
Duhok, Erbil and Sulaymaniyah hospitals to study 
the antibiotic resistant pattern, prevalence and geno-
type characterization of  highly virulent strains of  P. 
aeruginosa in Kurdistan.
MATERIALS AND METHOD
Bacterial strains 
A total of  101 strains of  P. aeruginosa were collect-
ed from both clinical and environmental sources. 
Most of  these were clinical isolates (n=87) which 
were obtained from hospitalized patients (both sexes 
and from different ages) in different wards at three 
major public hospitals in Kurdistan namely; Azadi-
Hospital in Duhok, Rizgari Hospital in Erbil and 
General Medicine Hospital in Sulaymaniyah. The 
clinical isolates were collected from variousinfection 
sources; including burn, middle ear, wound, respira-
tory tract (sputum and bronchial alveolar lavage) as 
well as urine samples. In contrast, the environmental 
isolates (n=14) were collected from soil samples of  
some animal farms at the above districts.
Isolation and identification of  P. aeruginosa 
strains
The isolates of  P. aeruginosa were initially identified 
using selective agar culture media according to the 
protocol described by Khan et al.,(26) with some mod-
ifications. Samples were cultured in brain heart in-
fusion broth at 37°C for 24 hours. Then, each sam-
ple was streaked on MacConkey agar and incubated 
for 24 hours at 37°C. A single suspected colony that 
showed the characteristic appearance was selected 
and plated onto the Cetrimide agar plate, incubated 
overnight at 42°C. Isolates were primarily identified 
as P. aeruginosa if  they showed growth at 42°C. Col-
onies were purified and transferred onto Pseudo-
monas Isolation Agar and incubated for 24 hours at 
37°C. A single purified colony was then inoculated 
into nutrient broth and incubated for 24 hours at 
37°C and then kept in 50% glycerol and stored at 
-20°C until used.
Antibiotic sensitivity testing
Screening for antibiotic resistance was performed 
by the Kirby Bauer disc diffusion method on Muel-
ler-Hinton agar as described by the Clinical and 
Laboratory Standards Institute (CLSI) guidelines(27). 
Fourteen of  commercially available antibiotic discs 
(Oxoid, Basingstoke,UK); including Ciprofloxacine 
(5µg), Piperacillin (100µg), Imipenem (10µg),Ami-
kacin (30µg), Ceftazidime (30µg), Chlorampheni-
col (30µg), Doxycycline (30µg), Gentamicin (10µg), 
Erythromycin (15µg), Cefotaxime (30µg), Amoxa-
cillin/Clavulanic Acid (30/10µg), Ticarcillin (75µg), 
Cefixime (5µg) and Tetrcyclin (30µg) were used 
against all isolates. Isolates that produced resistant 
to at least three antibiotics from different antibiotic 
classes were defined as multidrug-resistant, whereas 
isolates remain susceptible to only one or two anti-
biotics from all antimicrobial categories were identi-
fied as extensively drug-resistant(28).
Genomic DNA isolation and PCR amplifica-
tions
Genomic DNA was extracted from all 101 strains 
using High yield DNA Purification Kit as described 
in the supplier’s manual (Cinnagen-Iran). P. aerugino-
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sa isolates were identified at both genus and species 
level by duplex PCR(29) with minor modifications. 
The complete exoU gene was amplified, and se-
quenced (sequence data not included), using primers 
exoU-F (5’-ATGCATATCCAATCGTTGG-’3) and 
exoU-R (5’-CTAGCAATGGCACTAATCG-’3)(30). 
PCR amplifications were carried out using 200 µL 
PCR tube with a reaction mixture of  25 µL.  Each 
of  the reaction mixtures contained 10X PCR buffer, 
2.5mM each of  dATP, dCTP, dGTP and dTTP (Fer-
mentas), 1.5 mMol L-1 of  MgCl2, 1 U of  Taq poly-
merase (Fermentas), 10pmol µL-1 of  each primers, 
25-50ng of  bacterial DNA and milli-Q water up to 
25µl. PCR withthe following cycling parameters was 
performed:Initial denaturation at 94°C for 2min; 30 
cycles of  denaturation at 94°C for 1min, annealing 
at 55°C for 1min and extension at 72°C for 2min; 
and a final extension at 72°C for 7min. The internal-
ly transcribed spacer (ITS) region,located between 
the 16S and 23S rRNA genes, was amplified using 
primers PA1 5’-GCCCGTCACACCATGGGAG-’3 
and PA2 5’-TCGCCTSTGRRGCCAAGGC-’3 as 
previously described(31) and amplification reaction 
mixture described above. PCR program was as fol-
low:initial denaturation of  2 min at 94°C followed by 
30 cycles of  1 min at 94°C, 45s at 68°C, and 1 min at 
72°C, and a final extension at 72°C for 10 min. Am-
plified products were separated by electrophoresis 
on a 1.2% (W/V) agarose gels, stained with ethidium 
bromide and visualized by UV transilluminator. 
Cloning and sequencing of  ITS region
The PCR products were purified using QIAquick 
PCR purification Kit (Qiagen). The Purified PCR 
products then cloned into pGEM-T Easy Vector 
System I according to the manufacture’s manual 
(Promega) and the ligation mixture added to DH5α 
competent cells. Colony PCR was performed to 
confirm the presence of  target insert. The positive 
clones were subjected to plasmid extraction and se-
quencing.
Selection, amplification and sequencing of  the 
loci
The housekeeping genes acsA, aroE, guaA, mutL, 
nuoD, ppsA, and trpE(Table: 2) have been select-
ed according to the MLST scheme for P. aerugi-
nosa(http://pubmlst.org/paeruginosa/). MLST was 
performed according to the protocol published by 
Curran et al(22) with minor modifications. The house-
keeping genes were amplified using the amplification 
reaction mixture described above with adding PWO 
Taq polymerase. The reaction conditions were: dena-
turation at 94°C for 1 min, annealing at 58-60°C for 
1 min, and extension at 72°C for 1 min for 35 cycles 
with a final extension at 72°C for 5min. The ampli-
fied PCR products were purified with MinElute PCR 
Purification Kit (50) (Qiagen), according to the man-
ufacture’s protocol. Sequencing was carried out with 
internal nested primers as described at the http://
pubmlst.org/paeruginosa/info/primers.shtml web-
site. The purified PCR products were sequenced 
using a 48 capillary ABI 3730 Genetic analyser for 
Sanger sequencing in DNA Sequencing facility at-
The University of  Manchester-UK. 
Sequence data analysis
The forward and reverse sequences were imported, 
assembled, edited, trimmed and verified in Gene-
ious, version R8.1(32) and then saved in Fasta format. 
Positions in which gaps were present in any of  the 
aligned sequences were excluded from the analysis. 
All sequences were confirmed by individual BLAST 
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searches to determine whether the corresponding 
data matched well with the appropriate gene of  P. 
aeruginosa. The individual genes were estimated un-
der best-fit models of  nucleotide substitution se-
lected with jModel Test(33).The phylogenetic analyses 
performed by using GARLI web service hosted at 
molecularevolution.org(34) using GARLI 2.0 (Ge-
netic Algorithm for Rapid Likelihood Inference; 
Zwickl 2006). The partitioned model was selected, 
which allowed partitioning of  the data into six sub-
sets, namely acsA-trpE, aroE-guaA, mutL-exoU, nuoD, 
ppsA and ITS, each of  which were assigned separate 
evolutionary models, namely TPM1uf+I, HKY+I, 
TrN+I, HKY+G, HKY, and TPM1+I, respective-
ly.Confidence intervals for bootstrap probabilities 
based on 1000 replicates. The correlation between 
genetic distances with geographical distances and in-
fection sites were investigated using Mantel test in 
R (mantel.test). The significance threshold was set 
at 0.05.
Allele and sequence type assignment
The Pseudomonas aeruginosa MLST database at (http://
pubmlst.org/paeruginosa) was used to assign num-
bers to each distinct allele within a locus. Thus, each 
individual isolate was given seven numbers known as 
allele profile that yielded to its sequence type (ST). 
Any allele that did not match with existing alleles in 
the database was designated as a “new” allele. Any se-
quence type that did not match with the existing da-
tabase allele combination was numbered as a “new” 
sequence type. Isolates that share five or more iden-
tical alleles (single-or double-locus variants) were 
considered part of  the same clonal complex(26)(3).
Nucleotide sequence accession numbers
The nucleotide sequences determined in the cur-
rent study were submitted to GenBank. The ac-
cession numbers for the ITS region, exoU gene, 
acsA, aroE, guaA, mutL, nuoD, ppsA, and trpE-
genes are KX641417- KX641439, KX641440 - 
KX641462, KX773949 - KX773971, KX773972 
- KX773994,KX773995 - KX774017, KX774018 
- KX774040,KX821688-KX821710, KX774041 - 
KX774063 and KX774064 - KX774086, respective-
ly.
RESULTS AND DISCUSSIONS
In this study, the bacteriological results revealed that 
a total of  101 isolates of  P. aeruginosa were identified 
out of  523 specimens tested, representing 19.3% 
of  the total samples. According to their sources, 87 
were clinical and 14 were environmental isolates. All 
P. aeruginosa isolates that were identified by selective 
agar culture media, biochemical and microscopic 
tests, were confirmed at the genus and species level 
by 16S rDNA based PCR assay. Among the two sets 
of  primers used in a duplex PCR, the genus-specific 
primer pair (PA-GS) amplified an amplicon of  618 
bp corresponding with special band of  Pseudomonas 
genus and the species-specific primer pair (PA-SS) 
yielded an amplicon of  956 bp, corresponding with 
a special band of  P. aeruginosa in all the isolates tested. 
Thus, all the isolates were confirmed at the molecu-
lar level as P. aeruginosa by PCR.
The results of  antibiotic susceptibility for all iso-
lates were as follows: 18.81% (imipenem), 26.73% 
(ceftazidime), 39.60% (amikacin), 42.57% (cipro-
floxacin), 44.55% (cefotaxime), 49.50% (chloram-
phenicol), 58.41% (gentamicin), 64.35% (cefixime), 
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69.30% (piperacillin), 71.28% (ticarcillin), 73.26% 
(amoxacillin/clavulanic acid), 82.17% (erythromy-
cin), 84.15% (tetracycline) and 95.04% (doxycycline). 
Furthermore, 23.76% were found to be non-drug 
resistant isolates, 35.64% were extensively drug re-
sistant (XDR) isolates and 40.59% were found to be 
multidrug-resistant (MDR) strains.These results in-
dicate that patients infected by P. aeruginosa in this re-
gion are in high antibiotic resistance risk. Such high 
resistance rate could be explained by prior exposure 
to different types of  antibiotics and in empirical 
combination therapy. Also, the exceedingly using of  
these antibiotics, spread of  resistance strains, influx 
of  low quality and/or not always WHO prequalified 
antibiotics into the markets as well as self-medica-
tions might be the main reasons behind such high 
antibiotic resistant rates.
The results of  the prevalence of  exoU gene revealed 
that 23 out of  87 clinical isolates were exoU+ gen-
otypes representing 26.4% of  the total clinical iso-
lates (Figure: 1). This result was similar to previous 
survey (25.4%) carried out byGarey et al.,(14) in USA 
and slightly higher than that reported by Bradbury 
et al.,(35) in Tasmania which was18.0%. However, in 
our analysis, this rate was markedly lower than oth-
er studies conducted in Iran by Jabalameli et al.,(36), 
Yousefi-Avarvand et al.,(37) and Azimi et al., (38) who 
showed 64.5%, 65.4% and 52.0% of  exoU positive 
genotypes, respectively. This lower prevalence rate 
of  horizontally transferredexoUvirulence gene(39) in 
our studymight be due to the less clonal diversity of  
the studied isolates in Kurdistan. Furthermore, it was 
observed that all exoU+ P. aeruginosa were exclusive-
ly from clinical sources and not in any of  the envi-
ronmental isolates (Figure 1). However, this result is 
in contrast with the studies conducted by Bradbury 
et al.,(35) and Streeter et al.,(40) who reported the pres-
ence of  exoUgene in both environmental and clinical 
strains. The reason for this difference is unclear; it 
may reflect the genuine differences between P. aerugi-
nosa populations isolated from different geographical 
sites. However one must be cautious since false neg-
atives can be generated through a PCR based analy-
sis (30). What is clear is that the presence ofexoU gene 
is a variable trait in P. aeruginosa(38).
The distribution of  exoU+ isolates according to their 
geographical locations showed that the highest num-
ber (n=14 out of  23) of  exoU+ isolates were detected 
in Sulaymaniyah, whereas, the lowest number (n=1 
out of  23) were from Erbil (Figure 1), and there was 
a statistically significant difference between the loca-
tions and the prevalence of  the exoU virulence gene 
carriage (χ2d.f.=2, N=101, p = 0.0054). Further-
more, according to their infection sources, results re-
vealed thatexoU+ isolates were identified from nearly 
all infection sites (Figure 1). However, no statistically 
significant differences were observed between the 
infection sites and the prevalence of  exoU virulence 
gene (χ2d.f.=4, N=101, p = 0.878). This is mostly 
might be due to the fact that exoU+ strains have the 
ability to cause acute infections in almost all types 
of  human infections, as ExoU has been shown to 
acquire cytolytic activity to different cell types such 
as epithelial cells, macrophages and fibroblasts(4).
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Figure 1: Distribution of  the exoU+ P. aeruginosa isolates according to their locations and source 
of  infections.
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Genotyping analysis was performed for all the 
exoU+ isolates using MLST. The whole-gene se-
quence data for the seven loci obtained from PCR 
amplification primers, MLST fragment lengths data 
obtained from MLST nested primers and their vari-
able sites are given in Table 1. The allelic sequences 
obtained have been searched for in the P. aeruginosa 
MLST database at (http://pubmlst.org/paerugino-
sa). All allele sequences were found in the database 
and none of  the seven genes exhibited new alleles.
The number of  alleles per each loci were varied and 
ranged from six (ppsA) to 12 (aroE). The number of  
polymorphic sites obtained from MLST fragment 
lengths was generally low and ranged between five 
(ppsA) to 19 (aroE) in all studied loci (Table 1). This 
result is comparable with that obtained by(20) who re-
ported an overall low number of  polymorphic sites 
and low values of  the nucleotide diversity per site. 
The ratio of  non-synonymous to synonymous nu-
cleotide changes (dN/dS) was also calculated for all 
7 loci (Table 1) and found to be between 0.054% 
(trpE) and 2.69% (aroE). A ratio of  dN/dS<1 sug-
gests that genes are predominantly evolving by puri-
fying selection(20). 
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Table 1: Analysis of  the sevenloci of  the exoU+ P. aeruginosa isolates.
alleles Length (bp) No. of variable sites Length (bp)  % Variable 
acsA 10 810 41 390 17 4.35 0.094 
aroE 12 852 32 495 19 4.24 2.69 
guaA 7 843 33 372 7 1.88 1.83 
mutL 9 702 60 441 11 2.49 0.123 
nuoD 9 798 64 366 15 4.09 0.343 
ppsA 6 880 32 369 5 1.62 0.864 
trpE 8 774 24 441 16 3.62 0.054 
ITS - 659 9 - - - - 
No. of 
variable sites
In addition, if  a strain possessed a new allelic combination profile, at least one allele different among the 
seven examined genes, was classified as a new sequence type. The 23 exoU+ strains were assigned to 21 STs 
from which 16 new STs were identified. The allele combinations of  all new sequence types obtained were 
submitted and deposited in the P. aeruginosa MLST database at (http://pubmlst.org/paeruginosa) and ST 
numbers were given by the database. The allelic profiles for each genes analysed and their corresponding 
ST numbers are given in Table 2. To our knowledge, this is a first report investigating P. aeruginosa sequence 
types in Kurdistan.
Table 2. Infection source, location, MLST allelic profiles and sequence types of  
exoU+ P. aeruginosa isolates.
Isolate Source Location 
Allele Profile 
ST Note  acs aro gua mut  nuo pps  trp 
Pa-11 Urine Duhok 11 8 9 3 1 6 9 2195 New 
Pa-12 Respiratory Duhok 13 4 5 5 12 7 15 308  
Pa-14 Burn Sulaymaniyah 38 11 3 13 1 2 193 2196 New 
Pa-16 Middle Ear Sulaymaniyah 13 4 5 5 12 7 15 308  
Pa-17 Urine Sulaymaniyah 38 11 3 13 1 2 4 235  
Pa-18 Respiratory Sulaymaniyah 38 11 3 13 1 2 4 235  
Pa-19 Wound Duhok 9 13 3 6 64 33 42 1632  
Pa-20 Burn Sulaymaniyah 11 5 1 65 4 4 10 1516  
Pa-21 Burn Sulaymaniyah 38 11 3 65 13 2 10 2197 New 
Pa-22 Wound Sulaymaniyah 32 52 5 85 13 6 3 2198 New 
Pa-23 Burn Sulaymaniyah 38 11 3 13 22 2 3 2199 New 
Pa-24 Burn Sulaymaniyah 5 61 79 11 25 7 124 2200 New 
Pa-25 Burn Sulaymaniyah 38 11 3 13 91 2 3 2201 New 
Pa-26 Respiratory Duhok 13 75 5 5 12 7 15 481  
Pa-27 Burn Sulaymaniyah 38 11 3 13 1 2 3 2202 New 
Pa-28 Middle Ear Duhok 87 4 114 13 53 38 3 2203 New 
Pa-29 Respiratory Erbil 17 32 5 13 4 4 3 2204 New 
Pa-30 Burn  Sulaymaniyah 38 176 3 13 13 2 3 2205 New 
Pa-31 Wound Sulaymaniyah 38 150 3 11 13 2 3 2206 New 
Pa-32 Respiratory Duhok 82 75 5 133 13 7 3 2207 New 
Pa-33 Middle Ear Sulaymaniyah 38 150 3 11 12 2 3 2208 New 
Pa-34 Middle Ear Duhok 6 196 11 11 4 4 193 2209 New 
Pa-35 Urine Duhok 13 52 9 138 13 6 3 2210 New 
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All new STs except three were found to exhibit either 
MDR or XDR pattern. Furthermore, ST235 (which 
is globally known as a high risk clone(41)) was detect-
ed among two isolates typed in Sulaymaniyah. Also, 
ST308 (which is associated with different acquired 
β-lactamases, particularly IMP and VIM MBLs(42)) 
was identified in Duhok and Sulaymaniyah. The 
ST235 and ST308 in our hospitals were found to 
be highly drug-resistant and exoU+ genotypes. This 
might further confirm and provide evidence for the 
existence of  multidrug-resistant global clones, de-
nominated high-risk clones, circulating in hospitals 
worldwide. Different studies have been shown that 
ST235 (belongs to CC235) are commonly associated 
with the dissemination of  particular resistance genes 
especially those conferring resistance to clinically im
portant β-lactam antibiotics(43, 3). Detection of  these 
STs that exhibited XDR and highly virulent prop-
erties in our hospitals clearly represent one of  the 
most challenging pathogenic strains of  P. aeruginosa 
since ST235 strains are not only highly virulent and 
XDR which make them difficult to treat, but also po-
tent vectors for rapidly spreading and evolution of  
complex resistance loci. Therefore, monitoring of  
MDR- and exoU gene-carrying isolates has epidemi-
ological significance in the identification of  drug-re-
sistant and highly virulent P.aeruginosa isolates, espe-
cially in high-risk patients.
The internal transcribed spacer (ITS) located be-
tween the 16S and 23S rRNA genes, which is not 
subjected to the same selective pressure as the rRNA 
genes and the housekeeping genes, show more varia-
tions and consequently have a 10-times-greater evo-
lution rate. As such they have been widely used for 
phylogenetic analysis, typing and evolutionary stud-
ies(44). Therefore in order to allow better discrimina-
tion and greater tree robustness, the sequences of  the 
seven housekeeping genes, exoU and the ITS region 
for each strain were concatenated and used to con-
struct an unrooted phylogenetic tree among these 
strains.Thegenotypes were differentiated into five 
main groups in the phylogenetic tree supported by 
bootstrap values (Figure 2), i.e., Group I (which in-
cludes PA29, PA20), Group II (PA24, PA19), Group 
III (PA18, PA17), Group IV (PA35, PA32, PA34, 
PA33) Group V (PA16, PA12, PA26). However, 10 
isolates, which were all assigned as new STs, were not 
clustered with any of  these groups and found to be 
unrelated, sharing few if  any alleles. This might sug-
gest distinct evolutionary origins for each of  these 
new STs in Kurdistan.
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Figure 2: Phylogenetic relationship of  the clinical exoU+ P. aeruginosa isolates. 
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The genetic distances of  these isolate wereranged 
from 0.001- 0.019 substitution per site for all the 
pairwise comparisons made. In regard to compare 
few kb out of  ̴ 6Mbp of  P. aeruginosa genome, this 
result might indicates a mix of  closely related iso-
lates which have a recent common ancestorand 
some more distantly related strains among the test-
ed strain collection. Furthermore, results of  Mantel 
tests showed significant correlations between iso-
lates and their geographical area (p= 0.027), suggest-
ing that isolates from the same geographical location 
are closer to each other than isolates from different 
geographical areas.However, no statistically signif-
icant correlations were found between genetic dis-
tance and infection sites (p= 0.065). Results suggest 
that there is no particular correlation between the ge-
netic background of  these isolates and their specific 
infection sites. This result is compatible with exoU 
data discussed before and might further confirm the 
reliability of  MLST as a valuable tool for typing and 
epidemiological investigations.
11
ISSN: 2346-075X Bucaramanga - Colombia
CONCLUSIONS
Strains of  P. aeruginosa isolated from different geo-
graphical and infection sites displayed variations in 
their allelic profiles and STs which may reflect their 
adaptive ability to different environmental niches 
and diversity of  infections and diseases caused. Iso-
lates showed the coexistence of  exoU- and exoU+ 
genotypes of  clinical P. aeruginosa in Kurdistan. Pa-
tients infected by P. aeruginosa in this region are in 
high antibiotic resistance risk due to the prevalence 
of  high risk clone ofP. aeruginosa. Therefore, precise 
identifications and characterization of  this bacteri-
um in clinical settings and establishing the genetic 
relatedness among its highly pathogenic strains are 
crucial for the purposes of  long-term epidemiologi-
cal investigations and may have positive consequenc-
es in diagnosis, antimicrobial therapy, and infection 
control policies.
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